Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go?
Hashem B. El‐Serag, Fasiha Kanwal – 17 May 2014
Hashem B. El‐Serag, Fasiha Kanwal – 17 May 2014
Gabriel Gondolesi, Pablo Barros Schelotto, Esteban Halac, Pablo Romero, Marcelo Dip, Guillermo Cervio, Diego Ramisch, Francisco Klein, Silvia Niveyro, Guillermo Orce, Silvina Yantorno, Valeria Descalzi, Oscar Imventarza – 17 May 2014
Hashem B. El‐Serag, Fasiha Kanwal – 17 May 2014
Afshin Parsikia, Jorge Ortiz – 17 May 2014
Hashem B. El‐Serag, Fasiha Kanwal – 17 May 2014
Jackrapong Bruminhent, Raymund R. Razonable – 17 May 2014 – Cytomegalovirus (CMV) infection has been associated with poor outcomes after liver transplantation. Whether it is safe to perform transplantation for patients with active CMV viremia is not known. Here we report the outcomes of 6 patients with CMV viremia immediately before or at the time of liver transplantation.
Benjamin Israelow, Christopher M. Narbus, Marion Sourisseau, Matthew J. Evans – 16 May 2014 – Hepatitis C virus (HCV) exposure leads to persistent life‐long infections characterized by chronic inflammation often developing into cirrhosis and hepatocellular carcinoma. The mechanism by which HCV remains in the liver while inducing an inflammatory and antiviral response remains unclear.
Luca Maroni, Gianfranco Alpini, Marco Marzioni – 15 May 2014
Andreas Geier – 15 May 2014
Nicolas M. Intagliata, Hillary Maitland, Patrick G. Northup, Stephen H. Caldwell – 15 May 2014